Addendum: A phase II trial of cytoreductive surgery combined with niraparib maintenance in platinum-sensitive, secondary recurrent ovarian cancer: SGOG SOC-3 study

Author:

Shi Tingyan1ORCID,Xiang Libing1ORCID,Zhu Jianqing2ORCID,Liu Jihong3ORCID,Zhang Ping2ORCID,Wang Huaying4ORCID,Feng Yanling3ORCID,Zhu Tao2ORCID,Zhang Yingli2ORCID,Yu Aijun2ORCID,Jiang Wei5ORCID,Wang Xipeng6ORCID,Zhu Yaping7ORCID,Wu Sufang7ORCID,Teng Yincheng8ORCID,Zhang Jiejie2ORCID,Jiang Rong1ORCID,Zhang Wei9ORCID,Jia Huixun10ORCID,Zang Rongyu1ORCID

Affiliation:

1. Ovarian Cancer Program, Department of Gynecologic Oncology, Zhongshan Hospital, Fudan University, Shanghai, China.

2. Department of Gynecologic Oncology, The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, China.

3. Department of Gynecologic Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.

4. Department of Gynecologic Oncology, Fudan University Cancer Hospital, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.

5. Department of Gynecology, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China.

6. Department of Obstetrics and Gynecology, Xin Hua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

7. Department of Obstetrics and Gynecology, Shanghai General Hospital, Shanghai, China.

8. Department of Obstetrics and Gynecology, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

9. Department of Biostatistics, Fudan University, Shanghai, China.

10. Clinical Statistics Center, Shanghai General Hospital, Shanghai, China.

Publisher

Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology and Colposcopy

Subject

Obstetrics and Gynecology,Oncology,General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3